DISTRIBUTION OF IRON (II) BETWEEN BUFFERED AQUEOUS SOLUTIONS AND CHLOROFORM SOLUTION OF N,N’-ETHYLENEBIS(4-BUTANOYL-2,4-DIHYDRO-5-METHYL-2-PHENYL-3H-PYRAZOL-3-ONEIMINE)

The distribution of Fe(II) between buffered aqueous solution and chloroform solution of N,N’-Ethylenebis(4-butanoyl-2-4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-oneimine)(H2BuEtP) was investigated. The effect of 4-butanoyl-2-4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one(HBuP) in the distribution was also studied. Fe(II) concentration in aqueous raffinate was determined colorimetrically and distribution ratios and percentage extractions calculated by difference from Fe(II) in aqueous phase before and after equilibrations. The optimal pH for Fe(II) distribution slightly lowered to 8.00 in mixed ligands(H2BuEtP/HBuP) organic phase from 8.25 in ligand (H2BuEtP) alone organic phase. The pH range at which quantitative extraction of Fe(II) from aqueous buffered solution into both type of organic phases used for the study was very narrow. The extraction parameters; pH1/2, log D from extraction plots, and log Kex calculated using extraction equations derived from slope analysis showed that the values in both type of organic phases were very close even though mixed ligands(H2BuEtP/HBuP) organic phase values were slightly higher and better. Slope analysis also indicated that the Fe(II) complexes extracted into both organic phases were Fe(BuEtP)o and Fe(HBuEtP)(BuP)o respectively

Diameter distribution of Nauclea diderrichii (D Wild) Merr. Plantations in a restricted tropical rainforest of Nigeria

Distribution of tree diameter in a specific stand provides basic information for forest management. Little attention is given to the use of probability distribution functions in characterising the stem diameters of most Nigeria indigenous species. This study used Three-parameters lognormal and Weibull probability distribution functions in characterising the diameter of Nauclea diderrichii plantations within a restricted tropical rainforest of Nigeria for sustainable management. Thirty temporary sample plots of dimensions 20 m × 20 m were randomly laid in three age strata (42, 43 and 46 years). Stem diameters of all living Nauclea diderrichii trees with diameter at breast height ≥10.0 cm in all the sampled plots were enumerated. The performance and suitability result revealed that lognormal distribution gave superior description of the stem diameter for the Nauclea diderrichii species in the study area, with least values of Bias (0.00001), Mean absolute error (0.1214), Mean square error (0.7421), Kolmogorov-Smirnov (0.02781) and Anderson Darling (0.49562) statistics. Hence, three-parameter lognormal using maximum likelihood method was recommended for distributing stem diameter of Nauclea diderrichii in the study area.Keywords: Indigenous species; Lognormal; Maximum likelihood; Probability distribution function; Weibul

Characterization of Natural Ca-Bentonite Clays from Ebenebe in Anambra State, Nigeria, Impregnated with Ca(NO3)2, Zn(NO3)2 and KOH for use as Catalysts for Viscosity Reduction in Transesterification Reaction of Castor Oil

Natural Ca-Bentonite from Ebenebe in Anambra State, Nigeria, was successfully impregnated with Ca (NO3)2, Zn (NO3)2 and KOH and further calcined under different conditions of temperature and time using standard methods. Both the natural and impregnated bentonite clays were characterized using Fourier Transform Infrared Spectroscopy (FTIR), X-ray Fluorescence Spectroscopy (XRF) and Scanning Electron Microscopy (SEM) and then applied as catalysts in transesterification reaction of refined castor oil. Viscosity reduction test was used to ascertain the best catalyst for the transesterification. FTIR spectra of the activated clay catalysts show the formation of new functional groups, as the intensity of the Al-O-H stretching group (3633cm-1) of the natural clay increased with slightly higher wavelengths of 3640cm-1, 3644cm-1, 3644cm-1, 3644cm-1, 3640cm-1and 3644cm-1 for CaB2, CaB3, ZnB2, ZnB3 KB400, and KB700 catalysts respectively. XRF result identified the natural bentonite clay as Ca-bentonite clay with Ca-oxide having the most dominant component of 76.71%. XRF chemical compositions of the six activated Ca-bentonite clay catalysts when compared to the natural Ca-bentonite clay confirmed successful impregnation. The SEM images of all the prepared catalysts showed that impregnation and calcination changed the surface morphology of the natural clay. Finally, transesterification reactions of refined castor oil samples were done with 3%w/w natural and impregnated Ca-bentonite catalysts, methanol to oil ratio of 6:1, 2 hours reaction time and 65oC reaction temperature. Results obtained showed a descending order of catalyst viscosity reduction ability to be KB700 > CaB3 > CaB2 > ZnB3 >NCB > ZnB2 > KB400

Generalized lymphadenopathy: an unusual presentation of burkitt lymphoma in a Nigerian child: a case report

Intoduction: Burkitt Lymphoma is the fastest growing tumor in human and the commonest of the childhood malignancies. Generalized lymphadenopathy is a common feature of immunodeficiency associated Burkitt lymphoma but an uncommon presentation of the endemic type in Human Immunodeficiency Virus (HIV) negative children. Case presentation: The authors report a 6 year old HIV negative boy who presented with generalized lymphadenopathy, cough, weight loss, fever and drenching night sweat and had received native medication as well as treatment in private hospitals. His examination revealed hepatosplenomegaly, bull neck with generalized significant massive lymphadenopathy. Diagnosis was missed initially until a lymphnode biopsy for histology confirmed Burkitt lymphoma. He was managed on combination chemotherapy with complete resolution and now on follow up. Conclusion: To the best of our knowledge, this is the first documented report of its kind of endemic Burkitt lymphoma involving lymphnodes generally as the primary site. High index of suspicion and early biopsy are the key in this uncommon presentation

Stroke prevalence amongst sickle cell disease patients in Nigeria: a multi-centre study

Background: Stroke is a life-changing, debilitating complication of sickle cell disease (SCD). Previous studies had recorded high stroke prevalence amongst this group of patients. Nigeria has a large population of people affected by this condition and this study aims to assess the stroke prevalence in this large population.Methodology: Stroke prevalence data from 14 physicians working in 11 tertiary health centres across the country was collated by doctors using the sickle cell registers and patient case notes. This data was then collated and used to obtain the overall stroke prevalence in adult and children.Results: The stroke prevalence in sickle cell disease patients in Nigeria was observed to be 12.4 per 1000 patients. Prevalence in the adult patients was 17.7 per 1000 patients and 7.4 per 1000 patients in children. Twenty three percent of the affected patients had more than stroke episode.Conclusion: The stroke prevalence in Nigeria is lower than previously recorded rates and further studies will be required to investigate other factors which may play a role.Keywords: sickle cell, stroke, Nigeria, prevalenc

The influence of culture on entrepreneurial intentions: a Nigerian university graduates’ perspective

Culture influences entrepreneurship and it is becoming essential to determine its role in entrepreneurship development in different countries especially in those with cultural diversities like Nigeria where there are less studies. Nigeria included a compulsory variant of entrepreneurship education in the curriculum of universities to nurture entrepreneurial mind-sets. Despite the general recognition of the instrumentality and significance of entrepreneurship, there are no studies evaluating the programme or the role of culture in entrepreneurial intention development. This study applied an extended version of the theory of planned behaviour to examine the interaction between culture and entrepreneurship how this impact on the entrepreneurial intentions of graduates. This article analysed and reported results of the survey of 409 graduates from six universities using structural equation modelling-AMOS, analysis of moment structures. Findings indicate that culture has both direct and indirect effect on graduates’ entrepreneurial intentions. The study has implications for policy and practice

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

Background: The EMPA KIDNEY trial showed that empagliflozin reduced the risk of the primary composite outcome of kidney disease progression or cardiovascular death in patients with chronic kidney disease mainly through slowing progression. We aimed to assess how effects of empagliflozin might differ by primary kidney disease across its broad population. Methods: EMPA-KIDNEY, a randomised, controlled, phase 3 trial, was conducted at 241 centres in eight countries (Canada, China, Germany, Italy, Japan, Malaysia, the UK, and the USA). Patients were eligible if their estimated glomerular filtration rate (eGFR) was 20 to less than 45 mL/min per 1·73 m2, or 45 to less than 90 mL/min per 1·73 m2 with a urinary albumin-to-creatinine ratio (uACR) of 200 mg/g or higher at screening. They were randomly assigned (1:1) to 10 mg oral empagliflozin once daily or matching placebo. Effects on kidney disease progression (defined as a sustained ≥40% eGFR decline from randomisation, end-stage kidney disease, a sustained eGFR below 10 mL/min per 1·73 m2, or death from kidney failure) were assessed using prespecified Cox models, and eGFR slope analyses used shared parameter models. Subgroup comparisons were performed by including relevant interaction terms in models. EMPA-KIDNEY is registered with ClinicalTrials.gov, NCT03594110. Findings: Between May 15, 2019, and April 16, 2021, 6609 participants were randomly assigned and followed up for a median of 2·0 years (IQR 1·5–2·4). Prespecified subgroupings by primary kidney disease included 2057 (31·1%) participants with diabetic kidney disease, 1669 (25·3%) with glomerular disease, 1445 (21·9%) with hypertensive or renovascular disease, and 1438 (21·8%) with other or unknown causes. Kidney disease progression occurred in 384 (11·6%) of 3304 patients in the empagliflozin group and 504 (15·2%) of 3305 patients in the placebo group (hazard ratio 0·71 [95% CI 0·62–0·81]), with no evidence that the relative effect size varied significantly by primary kidney disease (pheterogeneity=0·62). The between-group difference in chronic eGFR slopes (ie, from 2 months to final follow-up) was 1·37 mL/min per 1·73 m2 per year (95% CI 1·16–1·59), representing a 50% (42–58) reduction in the rate of chronic eGFR decline. This relative effect of empagliflozin on chronic eGFR slope was similar in analyses by different primary kidney diseases, including in explorations by type of glomerular disease and diabetes (p values for heterogeneity all >0·1). Interpretation: In a broad range of patients with chronic kidney disease at risk of progression, including a wide range of non-diabetic causes of chronic kidney disease, empagliflozin reduced risk of kidney disease progression. Relative effect sizes were broadly similar irrespective of the cause of primary kidney disease, suggesting that SGLT2 inhibitors should be part of a standard of care to minimise risk of kidney failure in chronic kidney disease. Funding: Boehringer Ingelheim, Eli Lilly, and UK Medical Research Council

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Background: Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. // Methods: We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung's disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. // Findings: We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung's disease) from 264 hospitals (89 in high-income countries, 166 in middle-income countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in low-income countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. // Interpretation: Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between low-income, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030